GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders Growth (1y) (2023 - 2026)
GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.80% |
| Mar 31, 2026 | -30.10% |
| Dec 31, 2025 | -16.50% |
| Sep 30, 2025 | -1.28% |
| Jun 30, 2025 | 16.82% |
| Mar 31, 2025 | 57.22% |
| Dec 31, 2024 | 78.91% |
| Sep 30, 2024 | 25.33% |
| Jun 30, 2024 | 2.39% |
| Mar 31, 2024 | 97.88% |
| Dec 31, 2023 | -27.26% |
| Sep 30, 2023 | -23.00% |
| Jun 30, 2023 | -13.81% |
| Mar 31, 2023 | -51.41% |